微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 42.44% | -2.67% | -2.42% | 19/52 | 36.36% | 百奥赛图 | 74.91% | 行业排名> |
| 2025-06-30 | 43.49% | 3.17% | 2.24% | 18/52 | 36.49% | 百奥赛图 | 74.39% | 行业排名> |
| 2025-03-31 | 42.54% | -2.26% | 0.42% | 18/52 | 34.34% | *ST生物 | 64.96% | 行业排名> |
| 2024-12-31 | 42.36% | -17.2% | -2.86% | 18/52 | 35.25% | 百奥赛图 | 77.67% | 行业排名> |
| 2024-09-30 | 43.6% | -19.44% | 3.44% | 15/52 | 35.76% | *ST生物 | 68.03% | 行业排名> |
| 2024-06-30 | 42.15% | -20.57% | -3.14% | 17/52 | 36.65% | 百奥赛图 | 74.42% | 行业排名> |
| 2024-03-31 | 43.52% | -10.09% | -14.93% | 15/52 | 35.74% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 51.16% | 8.01% | -5.48% | 5/52 | 38.77% | 百奥赛图 | 70.59% | 行业排名> |
| 2023-09-30 | 54.13% | 15.35% | 2% | 5/52 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 53.07% | 12.86% | 9.63% | 5/52 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 48.4% | 6.98% | 2.19% | 9/52 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 47.37% | 6.85% | 0.95% | 16/52 | 40.75% | 百奥赛图 | 73.38% | 行业排名> |
| 2022-09-30 | 46.92% | 4.45% | -0.21% | 14/52 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 47.02% | 4.76% | 3.92% | 16/52 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 45.24% | 5.55% | 2.06% | 19/52 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 44.33% | -4.77% | -1.33% | 24/52 | 42.48% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 44.93% | -7.24% | 0.1% | 21/52 | 43.07% | *ST生物 | 84.53% | 行业排名> |
| 2021-06-30 | 44.88% | -7.62% | 4.71% | 24/52 | 42.6% | *ST生物 | 83.19% | 行业排名> |
| 2021-03-31 | 42.87% | -10.13% | -7.92% | 17/52 | 39.47% | *ST生物 | 83.9% | 行业排名> |
| 2020-12-31 | 46.55% | 2.3% | -3.88% | 20/52 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 48.43% | 8.62% | -0.32% | 9/52 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 48.59% | 9.86% | 1.87% | 12/52 | 39.28% | *ST生物 | 78.74% | 行业排名> |
| 2020-03-31 | 47.7% | 7.82% | 4.82% | 9/52 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 45.5% | -2.14% | 2.05% | 19/52 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 44.59% | -3.59% | 0.82% | 14/52 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 44.23% | -3.87% | -0.02% | 16/52 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 44.24% | -11.16% | -4.86% | 13/52 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 46.5% | -10.13% | 0.54% | 13/52 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 46.25% | -12.31% | 0.53% | 12/52 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 46.01% | -11.31% | -7.61% | 15/52 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 49.8% | 3.04% | -3.76% | 11/52 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 51.74% | 0.27% | -1.9% | 9/52 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 52.74% | -1.97% | 1.67% | 7/52 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 51.88% | 4.63% | 7.35% | 9/52 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 48.33% | 2% | -6.35% | 5/52 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 51.6% | 7.01% | -4.09% | 5/52 | 40.43% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 53.8% | 2% | 8.51% | 3/52 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 49.58% | 2% | 2.83% | 4/52 | 33.77% | 退市海医 | 95.27% | 行业排名> |